Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Sica

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Neurology and Therapy|November 8, 2019
Fingolimod Immune Effects Beyond Its Sequestration AbilityFrancesco Sica, Diego Centonze, Fabio Buttari
CNS & Neurological Disorders Drug Targets|April 12, 2013
Sundowning syndrome: a possible marker of frailty in Alzheimer's disease?Davide Ferrazzoli, Francesco Sica, Giuseppe Sancesario
Multiple Sclerosis and Related Disorders|April 26, 2025
Neuromuscular electrical stimulation reduces spinal excitability in Multiple Sclerosis patients with spasticity symptomsMartina Scalia, Riccardo Borzuola, Martina Parrella, et al.
Journal of Clinical Medicine|February 10, 2024
Neuromuscular Electrical Stimulation Does Not Influence Spinal Excitability in Multiple Sclerosis PatientsMartina Scalia, Riccardo Borzuola, Martina Parrella, et al.
CNS & Neurological Disorders Drug Targets|April 12, 2013
Electroencephalography and dementia: a literature review and future perspectivesDavide Ferrazzoli, Maria Albanese, Francesco Sica, et al.
Neurochemistry International|December 3, 2014
Levodopa-induced dyskinesias are associated with transient down-regulation of cAMP and cGMP in the caudate-putamen of hemiparkinsonian rats: reduced synthesis or increased catabolism?Giuseppe Sancesario, Luigi Antonio Morrone, Vincenza D'Angelo, et al.
Frontiers in Cellular Neuroscience|July 14, 2020
IL-6 in the Cerebrospinal Fluid Signals Disease Activity in Multiple SclerosisMario Stampanoni Bassi, Ennio Iezzi, Jelena Drulovic, et al.
Multiple Sclerosis and Related Disorders|February 13, 2018
Fingolimod reduces the clinical expression of active demyelinating lesions in MSElisabetta Signoriello, Doriana Landi, Fabrizia Monteleone, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|December 11, 2019
Practice-dependent motor cortex plasticity is reduced in non-disabled multiple sclerosis patientsMario Stampanoni Bassi, Fabio Buttari, Pierpaolo Maffei, et al.
JAMA Neurology|October 17, 2014
Orexinergic system dysregulation, sleep impairment, and cognitive decline in Alzheimer diseaseClaudio Liguori, Andrea Romigi, Marzia Nuccetelli, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Neurology and Therapy|November 8, 2019
Fingolimod Immune Effects Beyond Its Sequestration AbilityFrancesco Sica, Diego Centonze, Fabio Buttari
CNS & Neurological Disorders Drug Targets|April 12, 2013
Sundowning syndrome: a possible marker of frailty in Alzheimer's disease?Davide Ferrazzoli, Francesco Sica, Giuseppe Sancesario
Multiple Sclerosis and Related Disorders|April 26, 2025
Neuromuscular electrical stimulation reduces spinal excitability in Multiple Sclerosis patients with spasticity symptomsMartina Scalia, Riccardo Borzuola, Martina Parrella, et al.
Journal of Clinical Medicine|February 10, 2024
Neuromuscular Electrical Stimulation Does Not Influence Spinal Excitability in Multiple Sclerosis PatientsMartina Scalia, Riccardo Borzuola, Martina Parrella, et al.
CNS & Neurological Disorders Drug Targets|April 12, 2013
Electroencephalography and dementia: a literature review and future perspectivesDavide Ferrazzoli, Maria Albanese, Francesco Sica, et al.
Neurochemistry International|December 3, 2014
Levodopa-induced dyskinesias are associated with transient down-regulation of cAMP and cGMP in the caudate-putamen of hemiparkinsonian rats: reduced synthesis or increased catabolism?Giuseppe Sancesario, Luigi Antonio Morrone, Vincenza D'Angelo, et al.
Frontiers in Cellular Neuroscience|July 14, 2020
IL-6 in the Cerebrospinal Fluid Signals Disease Activity in Multiple SclerosisMario Stampanoni Bassi, Ennio Iezzi, Jelena Drulovic, et al.
Multiple Sclerosis and Related Disorders|February 13, 2018
Fingolimod reduces the clinical expression of active demyelinating lesions in MSElisabetta Signoriello, Doriana Landi, Fabrizia Monteleone, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|December 11, 2019
Practice-dependent motor cortex plasticity is reduced in non-disabled multiple sclerosis patientsMario Stampanoni Bassi, Fabio Buttari, Pierpaolo Maffei, et al.
JAMA Neurology|October 17, 2014
Orexinergic system dysregulation, sleep impairment, and cognitive decline in Alzheimer diseaseClaudio Liguori, Andrea Romigi, Marzia Nuccetelli, et al.
Pageof 2